The Subject Expert Committee (SEC), functional under the Central Drugs Standard Control Organisation (CDSCO), has asked ...

California has launched a program to manufacture and sell lower-cost insulin to people with diabetes. State officials say consumers will be able to purchase a five-pack of insulin pens for $55 in ...

Adocia and Tonghua Dongbao have announced positive topline results from a phase 3 clinical trial of BioChaperone Lispro ...

The new substance combines both insulin, the hormone that lowers blood sugar levels—and glucagon, which that increases them.

Adocia (Euronext Paris: FR0011184241 – ADOC, the "Company"), a clinical-stage biopharmaceutical company focused on the ...

Researchers at the Indiana University School of Medicine have discovered a new way to regulate blood glucose levels using a ...

California's first insulin pens will be for sale two years after the governor’s promised delivery date in 2024.

Long-acting insulin pens will be available at pharmacies for $11 per pen — or $55 for a five-pack — beginning Jan. 1.

Californians will be able to buy five packs of insulin pens for a maximum of $55 per pack, or $11 per pen, starting Jan. 1, ...

The sale of insulin is part of the state’s CalRx initiative aimed at lowering prescription drug prices for Californians.